Skip to main content

News

BAUS endorses expansion of Abiraterone access

The British Association of Urological Surgeons (BAUS) - driven by the Section of Oncology - strongly endorses NHS England’s decision to expand access to abiraterone for men with high-risk, non-metastatic prostate cancer. Read more

BAUS Welcomes Prostate Cancer Research Screening Report

Chair of BAUS Section of Oncology, Vish Hanchanale and BAUS President Prof. Ian Pearce BAUS welcomes the recently published report from Prostate Cancer Research, released as part of their ‘It’s High Time to Screen’ campaign, which... Read more

BAUS Endorses the Leng Review to Enhance Governance and Patient Safety

Following an independent review into Physician Associate (PA) and Anaesthesia Associate (AA) professionals by Professor Gillian Leng CBE – initially commissioned in November 2024 – the Leng Review was successfully published in July 2025. BAUS... Read more